CBS 2019
CBSMD教育中心
中 文

动脉粥样硬化性心血管疾病

Abstract

Recommended Article

Lipoprotein(a) in Alzheimer, Atherosclerotic, Cerebrovascular, Thrombotic, and Valvular Disease: Mendelian Randomization Investigation Apolipoprotein A-V is a potential target for treating coronary artery disease: evidence from genetic and metabolomic analyses Machine Learning Using CT-FFR Predicts Proximal Atherosclerotic Plaque Formation Associated With LAD Myocardial Bridging Plaque Rupture, compared to Plaque Erosion, is associated with Higher Level of Pan-coronary Inflammation Parallel Murine and Human Plaque Proteomics Reveals Pathways of Plaque Rupture Potential Mechanisms of In-stent Neointimal Atherosclerotic Plaque Formation Autologous CD34+ Stem Cell Therapy Increases Coronary Flow Reserve and Reduces Angina in Patients With Coronary Microvascular Dysfunction Independent Association of Lipoprotein(a) and Coronary Artery Calcification With Atherosclerotic Cardiovascular Risk

LetterJune 2, 2020 Vol 141, Issue 22

JOURNAL:Circulation. Article Link

Lipoprotein(a) in Alzheimer, Atherosclerotic, Cerebrovascular, Thrombotic, and Valvular Disease: Mendelian Randomization Investigation

SC Larsson, D Gill , AM Mason et al. Keywords: Lipoprotein(a); causal effect; CAD; valvular disease

Full Text PDF